Jan Dirk Jansen

Consultant and Interim Manager in the Dutch healthcare and pharmaceutical market

Netherlands

About

Previous 2012 - jan 2019; CEO of Pluripharm, a fast growing full line wholesaler and provider of various services to pharmacies, hospitals and patients in the Netherlands with a 500 million/year turnover and about 500 employees. 2008 - 2012: Consultant and Interim Manager in the Dutch healthcare and pharmaceutical market. Worked on strategy issues like "contracting primary care by national healthcare insurers", reorganizing drug distribution and introducing new business concepts for Mediq. 2001 - 2008: Pharmacy Director of LLOYDS in the Netherlands (Celesio AG). Responsible for strategy, sales, business development and public affairs. Participated as an expert in several of the European workgroups like the “Future Pharmacy” strategy workgroup. 1986 - 2001: Owner of a public pharmacy and medical centre from 1986 to 2001. Sidelines: Editor in chief of Farmamagazine, a magazine for pharmacists and other stakeholders in this sector. Chairman of the Pharmacists Association "Pact" Real Estate Development Specialties: Management in Healthcare and Pharma, strategy, sales, business development, innovation,

Experience

  • Consultant and Interim Manager in the Dutch pharmaceutical market at ZZP
    Feb 2019 - Present · 7 yrs 6 mos

  • CEO at Pluripharm
    Mar 2012 - Jan 2019 · 6 yrs 11 mos

    Responsible for general management, strategy and growth

  • Editor in chief (sideline) at Farmamagazine
    Jul 2010 - Jan 2014 · 3 yrs 7 mos

    Responsible for content, positioning the magazine in the market and business strategy

  • Chairman (sideline) at "Pharmacists Association Pact"'
    Jun 2012 - Jun 2013 · 1 yr 1 mo

  • Consultant and Interim Manager in the Dutch pharmaceutical market at ZZP
    2008 - 2012 · 4 yrs

    Consultant and Interim Manager in the Dutch pharmaceutical market. Worked on strategy issues like contracting primary care by national healthcare insurers, reorganizing drug distribution (through central filling) and other new business concepts for Mediq.